Why the study?
Does the presence of stage 2-5 chronic kidney disease increase the prevalence of left ventricular hypertrophy and alter left ventricular geometry in hypertensive patients compared to those with normal renal function?
Population
582 patients, comprising 293 hypertensive patients with stage 2-5 chronic kidney disease and 289 essential…
Design
Cross-sectional
Authors
Loading...
May warrant enhanced LV assessment in hypertensive CKD; extends cross-sectional links but leaves causal and therapeutic implications open.
Does the presence of stage 2-5 chronic kidney disease increase the prevalence of left ventricular hypertrophy and alter left ventricular geometry in hypertensive patients compared to those with normal renal function?
Left ventricular hypertrophy is highly prevalent and often inappropriate in hypertensive patients with chronic kidney disease, characterized by simultaneous increases in wall thickness and diameters.
Nardi et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: